215 related articles for article (PubMed ID: 35264437)
1. Necroptosis-driving genes
Nicolè L; Sanavia T; Cappellesso R; Maffeis V; Akiba J; Kawahara A; Naito Y; Radu CM; Simioni P; Serafin D; Cortese G; Guido M; Zanus G; Yano H; Fassina A
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264437
[TBL] [Abstract][Full Text] [Related]
2. Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma.
Lomphithak T; Akara-Amornthum P; Murakami K; Hashimoto M; Usubuchi H; Iwabuchi E; Unno M; Cai Z; Sasano H; Jitkaew S
Sci Rep; 2021 Jun; 11(1):11743. PubMed ID: 34083572
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus non-structural protein 4 usurps host cellular RIPK1-RIPK3 complex to induce MLKL-dependent necroptotic cell death.
Chandra P; Patra U; Mukhopadhyay U; Mukherjee A; Halder P; Koley H; Chawla-Sarkar M
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119745. PubMed ID: 38719029
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of necroptosis markers RIPK3/MLKL and their crosstalk with autophagy-related protein Beclin-1 in primary immune thrombocytopenia.
Kamal AM; Nabih NA; Rakha NM; Sanad EF
Clin Exp Med; 2023 Jun; 23(2):447-456. PubMed ID: 35699825
[TBL] [Abstract][Full Text] [Related]
5. Sublethal necroptosis signaling promotes inflammation and liver cancer.
Vucur M; Ghallab A; Schneider AT; Adili A; Cheng M; Castoldi M; Singer MT; Büttner V; Keysberg LS; Küsgens L; Kohlhepp M; Görg B; Gallage S; Barragan Avila JE; Unger K; Kordes C; Leblond AL; Albrecht W; Loosen SH; Lohr C; Jördens MS; Babler A; Hayat S; Schumacher D; Koenen MT; Govaere O; Boekschoten MV; Jörs S; Villacorta-Martin C; Mazzaferro V; Llovet JM; Weiskirchen R; Kather JN; Starlinger P; Trauner M; Luedde M; Heij LR; Neumann UP; Keitel V; Bode JG; Schneider RK; Tacke F; Levkau B; Lammers T; Fluegen G; Alexandrov T; Collins AL; Nelson G; Oakley F; Mann DA; Roderburg C; Longerich T; Weber A; Villanueva A; Samson AL; Murphy JM; Kramann R; Geisler F; Costa IG; Hengstler JG; Heikenwalder M; Luedde T
Immunity; 2023 Jul; 56(7):1578-1595.e8. PubMed ID: 37329888
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.
Pan QZ; Pan K; Zhao JJ; Chen JG; Li JJ; Lv L; Wang DD; Zheng HX; Jiang SS; Zhang XF; Xia JC
Cancer Immunol Immunother; 2013 Nov; 62(11):1675-85. PubMed ID: 24061617
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in key necroptosis regulators predict prognosis of non-small cell lung cancer after surgical resection.
Lee JH; Park JE; Hong MJ; Choi JE; Kang HG; Do SK; Lee S; Jeong JY; Shin KM; Do YW; Lee EB; Lee WK; Oh IJ; Kim YC; Choi SH; Lee YH; Seo H; Lee J; Cha SI; Kim CH; Yoo SS; Lee SY; Park JY
Thorac Cancer; 2023 Sep; 14(26):2678-2686. PubMed ID: 37519036
[TBL] [Abstract][Full Text] [Related]
8. BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.
Najafov A; Zervantonakis IK; Mookhtiar AK; Greninger P; March RJ; Egan RK; Luu HS; Stover DG; Matulonis UA; Benes CH; Yuan J
PLoS Biol; 2018 Aug; 16(8):e2005756. PubMed ID: 30157175
[TBL] [Abstract][Full Text] [Related]
9. Acetylshikonin induces necroptosis via the RIPK1/RIPK3-dependent pathway in lung cancer.
Lin SS; Chang TM; Wei AI; Lee CW; Lin ZC; Chiang YC; Chi MC; Liu JF
Aging (Albany NY); 2023 Dec; 15(24):14900-14914. PubMed ID: 38126996
[TBL] [Abstract][Full Text] [Related]
10. OSW-1 triggers necroptosis in colorectal cancer cells through the RIPK1/RIPK3/MLKL signaling pathway facilitated by the RIPK1-p62/SQSTM1 complex.
Wang N; Li CY; Yao TF; Kang XD; Guo HS
World J Gastroenterol; 2024 Apr; 30(15):2155-2174. PubMed ID: 38681991
[TBL] [Abstract][Full Text] [Related]
11. Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis.
Mohammed S; Thadathil N; Ohene-Marfo P; Tran AL; Van Der Veldt M; Georgescu C; Oh S; Nicklas EH; Wang D; Haritha NH; Luo W; Janknecht R; Miller BF; Wren JD; Freeman WM; Deepa SS
Mol Cancer Res; 2023 Sep; 21(9):933-946. PubMed ID: 37204757
[TBL] [Abstract][Full Text] [Related]
12. Cognitive enhancing effects of pazopanib in D‑galactose/ovariectomized Alzheimer's rat model: insights into the role of RIPK1/RIPK3/MLKL necroptosis signaling pathway.
Abdelhady R; Younis NS; Ali O; Shehata S; Sayed RH; Nadeem RI
Inflammopharmacology; 2023 Oct; 31(5):2719-2729. PubMed ID: 37458952
[TBL] [Abstract][Full Text] [Related]
13. Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis.
Qian F; Kong W; Wang S; Wei K
Clin Exp Med; 2023 Oct; 23(6):2087-2104. PubMed ID: 36271962
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes.
Montalban-Bravo G; Class CA; Ganan-Gomez I; Kanagal-Shamanna R; Sasaki K; Richard-Carpentier G; Naqvi K; Wei Y; Yang H; Soltysiak KA; Chien K; Bueso-Ramos C; Do KA; Kantarjian H; Garcia-Manero G
Leukemia; 2020 Mar; 34(3):872-881. PubMed ID: 31719677
[TBL] [Abstract][Full Text] [Related]
15. RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer.
Li F; Sun H; Yu Y; Che N; Han J; Cheng R; Zhao N; Guo Y; Huang C; Zhang D
Cell Death Dis; 2023 May; 14(5):335. PubMed ID: 37217473
[TBL] [Abstract][Full Text] [Related]
16. IE1 of Human Cytomegalovirus Inhibits Necroptotic Cell Death via Direct and Indirect Modulation of the Necrosome Complex.
Heusel AT; Rapp S; Stamminger T; Scherer M
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400065
[TBL] [Abstract][Full Text] [Related]
17. Anti-Necroptotic Effects of Itaconate and its Derivatives.
Ni ST; Li Q; Chen Y; Shi FL; Wong TS; Yuan LS; Xu R; Gan YQ; Lu N; Li YP; Zhou ZY; Xu LH; He XH; Hu B; Ouyang DY
Inflammation; 2024 Feb; 47(1):285-306. PubMed ID: 37759136
[TBL] [Abstract][Full Text] [Related]
18. Necroptosis pathways in tumorigenesis.
Zhang T; Wang Y; Inuzuka H; Wei W
Semin Cancer Biol; 2022 Nov; 86(Pt 3):32-40. PubMed ID: 35908574
[TBL] [Abstract][Full Text] [Related]
19. Targeting necroptosis in fibrosis.
Hassanein EHM; Ibrahim IM; Abd El-Maksoud MS; Abd El-Aziz MK; Abd-Alhameed EK; Althagafy HS
Mol Biol Rep; 2023 Dec; 50(12):10471-10484. PubMed ID: 37910384
[TBL] [Abstract][Full Text] [Related]
20. Necroptosis-related signatures identify two distinct hepatocellular carcinoma subtypes: Implications for predicting drug sensitivity and prognosis.
Tang H; Qiao C; Guo Z; Geng R; Sun Z; Wang Y; Bai C
Heliyon; 2023 Jul; 9(7):e18136. PubMed ID: 37519654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
